Announced Thu, 13 Aug · 16:55 IST
Disclosure of authorized persons for materiality determination
THEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+3.1%1-day move
₹103.79
prior close
₹103.96
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.4+0.3-0.6+0.0+3.1+2.1+1.1-0.8+2.1+14.8+15.9+15.7——
Up moveDown movePending
AI summary
Themis Medicare has filed a routine SEBI compliance disclosure under Regulation 30(5), listing four authorized persons who will determine materiality of events and make disclosures to stock exchanges. They are Executive-Chairman Dr. Dinesh S. Patel, MD and CEO Dr. Sachin D. Patel, Company Secretary Mr. Suresh Savaliya, and CFO Mr. Tushar Dalal. Mr. Savaliya is the single point of contact.
Likely market impact
No business or stock impact. This is a standard procedural compliance filing required of all listed companies.